Eagle Pharmaceuticals Revenue 2013-2023 | EGRX
Eagle Pharmaceuticals revenue from 2013 to 2023. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
| Eagle Pharmaceuticals Annual Revenue (Millions of US $) |
|
|---|---|
| 2022 | $317 |
| 2021 | $172 |
| 2020 | $188 |
| 2019 | $196 |
| 2018 | $213 |
| 2017 | $237 |
| 2016 | $189 |
| 2015 | $66 |
| 2014 | $ |
| 2014 | $19 |
| 2013 | $14 |
| 2012 | $ |
| 2012 | $3 |
| 2011 | $3 |
| Eagle Pharmaceuticals Quarterly Revenue (Millions of US $) |
|
|---|---|
| 2023-06-30 | $65 |
| 2023-03-31 | $66 |
| 2022-12-31 | $61 |
| 2022-09-30 | $66 |
| 2022-06-30 | $74 |
| 2022-03-31 | $116 |
| 2021-12-31 | $42 |
| 2021-09-30 | $40 |
| 2021-06-30 | $48 |
| 2021-03-31 | $41 |
| 2020-12-31 | $50 |
| 2020-09-30 | $50 |
| 2020-06-30 | $42 |
| 2020-03-31 | $46 |
| 2019-12-31 | $48 |
| 2019-09-30 | $41 |
| 2019-06-30 | $57 |
| 2019-03-31 | $50 |
| 2018-12-31 | $56 |
| 2018-09-30 | $51 |
| 2018-06-30 | $59 |
| 2018-03-31 | $47 |
| 2017-12-31 | $47 |
| 2017-09-30 | $63 |
| 2017-06-30 | $50 |
| 2017-03-31 | $77 |
| 2016-12-31 | $81 |
| 2016-09-30 | $38 |
| 2016-06-30 | $41 |
| 2016-03-31 | $30 |
| 2015-12-31 | $18 |
| 2015-09-30 | $6 |
| 2015-06-30 | $6 |
| 2015-03-31 | $36 |
| 2014-12-31 | $6 |
| 2014-09-30 | $3 |
| 2014-06-30 | $6 |
| 2014-03-31 | $5 |
| 2013-12-31 | $5 |
| 2013-09-30 | $5 |
| 2013-06-30 | $5 |
| 2013-03-31 | $2 |
| 2012-09-30 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.010B | $0.317B |
| Eagle Pharmaceuticals, Inc. is a specialty pharmaceutical company. It focuses on developing and commercializing injectable products primarily in the critical care and oncology areas in the United States. The Company markets EP-1101 to treat heparin-induced thrombocytopenia. It develops EP-3101, EP-3102, Ryanodex and EP-4104. Eagle Pharmaceuticals, Inc. is based in Woodcliff Lake, New Jersey. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $196.653B | 25.08 |
| Stryker (SYK) | United States | $142.804B | 32.18 |
| Boston Scientific (BSX) | United States | $132.807B | 38.18 |
| EssilorLuxottica (ESLOY) | France | $110.936B | 0.00 |
| Medtronic (MDT) | Ireland | $105.763B | 15.71 |
| Haleon (HLN) | United Kingdom | $44.180B | 28.71 |
| Lonza Group Ag (LZAGY) | Switzerland | $43.076B | 0.00 |
| GE HealthCare Technologies (GEHC) | United States | $37.052B | 19.22 |
| ResMed (RMD) | United States | $35.014B | 28.77 |
| Terumo (TRUMY) | Japan | $29.635B | 41.85 |
| Koninklijke Philips (PHG) | Netherlands | $24.241B | 18.55 |
| Zimmer Biomet Holdings (ZBH) | United States | $21.249B | 13.53 |
| Insulet (PODD) | United States | $18.893B | 75.23 |
| Baxter (BAX) | United States | $15.481B | 10.07 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.161B | 0.00 |
| BellRing Brands (BRBR) | United States | $10.045B | 40.41 |
| Bio-Rad Laboratories (BIO) | United States | $9.415B | 32.00 |
| Demant (WILYY) | Denmark | $8.300B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $6.467B | 15.03 |
| Haemonetics (HAE) | United States | $4.078B | 19.90 |
| Prestige Consumer Healthcare (PBH) | United States | $4.066B | 20.22 |
| ICU Medical (ICUI) | United States | $3.958B | 37.68 |
| Perrigo (PRGO) | Ireland | $3.745B | 11.02 |
| Envista Holdings (NVST) | United States | $3.351B | 24.96 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.010B | 0.00 |
| GN Store Nord (GNNDY) | Denmark | $2.928B | 18.78 |
| QuidelOrtho (QDEL) | United States | $2.781B | 17.90 |
| Neogen (NEOG) | United States | $2.633B | 30.37 |
| LeMaitre Vascular (LMAT) | United States | $2.264B | 55.02 |
| Green Thumb Industries (GTBIF) | United States | $1.710B | 29.93 |
| AtriCure (ATRC) | United States | $1.544B | 0.00 |
| InMode (INMD) | Israel | $1.534B | 9.22 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.432B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.285B | 9.18 |
| BioLife Solutions (BLFS) | United States | $1.239B | 0.00 |
| Owens & Minor (OMI) | United States | $1.075B | 8.40 |
| CeriBell (CBLL) | United States | $1.047B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $1.031B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.918B | 16.19 |
| Evolus (EOLS) | United States | $0.729B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.635B | 28.07 |
| Capricor Therapeutics (CAPR) | United States | $0.603B | 0.00 |
| Surmodics (SRDX) | United States | $0.573B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.488B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.445B | 0.00 |
| Omeros (OMER) | United States | $0.442B | 0.00 |
| Quanterix (QTRX) | United States | $0.410B | 0.00 |
| ZimVie (ZIMV) | United States | $0.379B | 31.93 |
| Biote (BTMD) | United States | $0.346B | 7.58 |
| Viemed Healthcare (VMD) | United States | $0.340B | 32.37 |
| Canopy Growth (CGC) | Canada | $0.339B | 0.00 |
| Valneva SE (VALN) | France | $0.319B | 0.00 |
| Cerus (CERS) | United States | $0.318B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.303B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.292B | 19.55 |
| Zynex (ZYXI) | United States | $0.259B | 54.27 |
| High Tide (HITI) | Canada | $0.257B | 106.33 |
| Aurora Cannabis (ACB) | Canada | $0.236B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.213B | 14.73 |
| MacroGenics (MGNX) | United States | $0.201B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.187B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.176B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.173B | 2.43 |
| Brainsway (BWAY) | Israel | $0.157B | 94.20 |
| FitLife Brands (FTLF) | United States | $0.156B | 19.65 |
| Quipt Home Medical (QIPT) | United States | $0.130B | 0.00 |
| Jin Medical (ZJYL) | China | $0.121B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.119B | 0.00 |
| Veru (VERU) | United States | $0.106B | 0.00 |
| Exagen (XGN) | United States | $0.102B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.100B | 0.00 |
| Fonar (FONR) | United States | $0.098B | 11.09 |
| Rockwell Medical (RMTI) | United States | $0.066B | 34.00 |
| Apyx Medical (APYX) | United States | $0.063B | 0.00 |
| InterCure (INCR) | Israel | $0.060B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.056B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.055B | 0.00 |
| Modular Medical (MODD) | United States | $0.055B | 0.00 |
| Safety Shot (SHOT) | United States | $0.050B | 0.00 |
| ImmuCell (ICCC) | United States | $0.044B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.022B | 0.00 |
| Flora Growth (FLGC) | United States | $0.017B | 0.00 |
| Nephros (NEPH) | United States | $0.016B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.015B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.011B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.007B | 0.00 |
| Agape ATP (ATPC) | $0.006B | 0.00 | |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| Senestech (SNES) | United States | $0.004B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.004B | 0.00 |
| Sharps Technology (STSS) | United States | $0.004B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.001B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.001B | 0.00 |
| United-Guardian (UG) | United States | $0.000B | 12.93 |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |